Connect With the Companies Defining the Future of In Vivo CAR-T

The 5th In Vivo Cell Engineering & Gene Editing Summit has rapidly evolved into a focal meeting point for in vivo CAR-T innovation. With the space accelerating from preclinical promise to clinical validation, this summit positions your organization directly in front of decision-makers driving next-generation in vivo CAR-Ts and gene therapies.

Momentum in the field was underscored recently by Eli Lilly’s landmark partnership with Kelonia Therapeutics, the largest in vivo CAR-T deal to date, signaling strong pharma commitment to scalable, in vivo approaches to cell therapy.

Partnering this year signals that your services, expertise, and capabilities align with where the field is heading next and ensures your brand is front‑of‑mind as developers prepare the next wave of in vivo programs.

why partner image - 5th in vivo cell engineering & gene editing summit

In Vivo CAR-T: The Deal-Making Hotspot in Cell Therapy

Across 2025 and 2026, the in vivo CAR-T landscape has seen accelerating deal activity, reflecting strong commercial validation from biopharma and investment communities.

Key highlighted transactions include:

  • Eli Lilly & Kelonia Therapeutics (2026) – Largest in vivo CAR-T deal to date
  • AbbVie & Capstan Therapeutics (2025) – Strategic acquisition strengthening in vivo CAR-T pipelines
  • Transactions involving Kite Pharma, Bristol Myers Squibb, and AstraZeneca are reinforcing competitive urgency

This surge in deal-making is driving demand for delivery technologies, CDMO scale-up, and translational expertise across the in vivo CAR-T ecosystem.

Top deals in 2025 for in vivo CAR therapies

What to Expect as a Partner?

Meet High‑Intent Prospects

Engage facetoface with R&D, translational, CMC, and business development leaders seeking partners for manufacturing, delivery optimization, analytical development, safety testing, and INDenabling support. 

Strengthen Your Position in a Competitive Market

Place your brand directly in front of companies preparing the next wave of editing, delivery, and early clinical programs, ensuring your organization is seen as ready to support this shift. 

Demonstrate Your Expertise

Showcase your capabilities through speaking opportunities, panel participation, or a tailored exhibition presence designed to highlight your unique strengths in supporting in vivo development.

Gain Real‑Time Market Intelligence

Key Interest Areas

Our attendees are actively seeking partners with capabilities across the in vivo development ecosystem, including but not limited to the areas below.

Non-Viral Vector CDMOs & Technology Providers

Acrpss lipid nanoparticles (LNPs), novel delivery systems, targeting and cell-specific uptake solutions enabling in vivo CAR-T

Viral Vector CDMOs & Technology Providers

Specializing in optimized AAV and lentiviral platforms supporting in vivo gene delivery

Global CRO Organizations

From preclinical through early clinical support for in vivo CAR-T pipelines

Preclinical Model Providers

Across relevant disease and immune models, validating in vivo CAR-T efficacy and safety

Other Solutions for In Vivo Drug Developers

Including analytics, CMC, regulatory, and enabling technologies

Position Yourself at the Center of In Vivo CAR-T Progress

As in vivo CAR-T transitions from an experimental concept to an investable modality, we can position your organization at this summit to demonstrate leadership and relevance in one of the most competitive areas of precision medicine. Align your brand with the companies shaping the next wave of immuno-oncology and autoimmune therapeutics. 

Audience Composition

Company Type

5th in vivo cell engineering attendee company type graph

Attendee Seniority

5th in vivo cell engineering attendee seniority graph

Attending Companies Include

Moderna - 5th In Vivo Cell Engineering & Gene Editing Summit
AstraZeneca - 5th In Vivo Cell Engineering & Gene Editing Summit
Azalea Therapeutics - 5th In Vivo Cell Engineering & Gene Editing Summit
CorriXR Therapeutics - 5th In Vivo Cell Engineering & Gene Editing Summit
GigaMune - 5th In Vivo Cell Engineering & Gene Editing Summit
Innorna - 5th In Vivo Cell Engineering & Gene Editing Summit
Kite Pharma - 5th In Vivo Cell Engineering & Gene Editing Summit
OneChain Immunotherapeutics - 5th In Vivo Cell Engineering & Gene Editing Summit
Sana Biotechnology logo - 5th In Vivo Cell Engineering & Gene Editing Summit
Eli Lilly - 5th In Vivo Cell Engineering & Gene Editing Summit
AbbVie - 5th In Vivo Cell Engineering & Gene Editing Summit
Regeneron - 5th In Vivo Cell Engineering & Gene Editing Summit
Legend Biotech - 5th In Vivo Cell Engineering & Gene Editing Summit

Available Inventory

We offer a range of partnership opportunities designed to elevate your visibility, demonstrate your expertise, and position your organization as a critical partner in the fast-growing in vivo cell engineering and gene editing space. 

inventory presenting slots
inventory leading innovation
inventory full delegate list
inventory exhibiting
inventory networking
inventory bespoke hosting
inventory champion the industry
inventory branding

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Jake Bennett

Partnerships Director

maintain competitive edge image - 5th in vivo cell engineering & gene editing summit
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

network with decision makers image - 5th in vivo cell engineering & gene editing summit
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

showcase your capabilities image - 5th in vivo cell engineering & gene editing summit
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.